20 ML immune globulin subcutaneous (human) - hipp 16.5 % (3.3 GM per 20 ML) Injection
- RxCUI
- 2167160
- RxNorm name
- 20 ML immune globulin subcutaneous (human) - hipp 16.5 % (3.3 GM per 20 ML) Injection
- Display name
- 20 ML immune globulin subcutaneous (human) - hipp 16.5 % (3.3 GM per 20 ML) Injection
- Full name
- 20 ML immune globulin subcutaneous (human) - hipp 16.5 % (3.3 GM per 20 ML) Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:27
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125668 | Cutaquig | Immune Globulin Subcutaneous (Human)-hipp | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f199187a-de4e-2047-0aee-b6d93390b3d2 | immune globulin subcutaneous (human) - hipp 16.5 % (3.3 GM in 20 mL) Injection [PSN] · 20 ML immune globulin subcutaneous (human) - hipp 165 MG/ML Injection [SCD] · 20 ML immune globulin subcutaneous (human) - hipp 16.5 % (3.3 GM per 20 ML) Injection [SY] | 3 | 15 | These highlights do not include all the information needed to use CUTAQUIG safely and effectively. See full prescribing information for CUTAQUIG. CUTAQUIG® (Immune Globulin Subcutaneous (Human) - hipp), 16.5% solution Initial U.S. Approval: 2018 | 20250324 |
| f3de095f-791a-85dc-7a14-ec7790cb13aa | immune globulin subcutaneous (human) - hipp 16.5 % (3.3 GM in 20 mL) Injection [PSN] · 20 ML immune globulin subcutaneous (human) - hipp 165 MG/ML Injection [SCD] · 20 ML immune globulin subcutaneous (human) - hipp 16.5 % (3.3 GM per 20 ML) Injection [SY] | 3 | 13 | These highlights do not include all the information needed to use CUTAQUIG safely and effectively. See full prescribing information for CUTAQUIG. CUTAQUIG® (Immune Globulin Subcutaneous (Human) - hipp), 16.5% solution Initial U.S. Approval: 2018 | 20211130 |